Cite
Tiraboschi JM, Rojas J, Zetterberg H, et al. No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62). J Infect Dis. 2021;223(11):1928-1933doi: 10.1093/infdis/jiaa645.
Tiraboschi, J. M., Rojas, J., Zetterberg, H., Blennow, K., Niubo, J., Gostner, J., Navarro-Alcaraz, A., Piatti, C., Fuchs, D., Gisslén, M., Rigo-Bonnin, R., Martinez, E., & Podzamczer, D. (2021). No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62). The Journal of infectious diseases, 223(11), 1928-1933. https://doi.org/10.1093/infdis/jiaa645
Tiraboschi, Juan M, et al. "No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62)." The Journal of infectious diseases vol. 223,11 (2021): 1928-1933. doi: https://doi.org/10.1093/infdis/jiaa645
Tiraboschi JM, Rojas J, Zetterberg H, Blennow K, Niubo J, Gostner J, Navarro-Alcaraz A, Piatti C, Fuchs D, Gisslén M, Rigo-Bonnin R, Martinez E, Podzamczer D. No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62). J Infect Dis. 2021 Jun 04;223(11):1928-1933. doi: 10.1093/infdis/jiaa645. PMID: 33049035.
Copy
Download .nbib